Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

Phase 2 Completed 31 enrolled Novo Nordisk A/S

RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare the glycaemic control of biphasic insulin aspart 70 + biphasic insulin aspart 30 with biphasic human insulin 30 in subjects with type 2 diabetes.

Timeline

Start: 2002-05
Primary completion: 2002-11
Completion: 2002-11

Publications

Results Dashora U, Ashwell SG, Home PD. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes. Diabetes Obes Metab. 2009 Jul;11(7):680-7. doi: 10.1111/j.1463-1326.2008.01024.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	biphasic human insulin 30	Unknown	—	Subcutaneous
Subject	biphasic insulin aspart 30	Protein / enzyme biologic	—	Subcutaneous
Subject	biphasic insulin aspart 70	Unknown	—	Subcutaneous

Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

Summary

Timeline

Publications

Drugs

Indications